NCT03406390

Brief Summary

Pterygium is the growth of conjunctival tissue onto the cornea, usually from the nasal quadrant of the cornea.Visual acuity may be reduced due to direct invasion of the visual axis or astigmatism induced by the pterygium. Contrast sensitivity measures two variables, size, and contrast which could comprehensively reflect the visual quality of the primary pterygium patients. In this study, we would investigate the the effects of primary pterygium on contrast sensitivity preoperatively and on the 1st, 3rd and 6th month postoperatively, moreover, the related parameters on the contrast sensitivity in the primary pterygium patients would be analyzed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2017

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

November 3, 2017

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 23, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

January 23, 2018

Status Verified

January 1, 2018

Enrollment Period

1 year

First QC Date

November 3, 2017

Last Update Submit

January 13, 2018

Conditions

Keywords

contrast sensitivityPterygium

Outcome Measures

Primary Outcomes (1)

  • The contrast sensitivity function tested by quick CSF of the Primary Pterygium patients preoperatively

    The contrast sensitivity function of the Primary Pterygium patients is lower than the normal people by qucik CSF method

    Preoperatively

Secondary Outcomes (1)

  • The contrast sensitivity function tested by quick CSF of the Primary Pterygium patients postoperatively

    1st, 3rd and 6th month postoperatively

Study Arms (1)

primary pterygium

Observe the contrast sensitivity of primary pterygium patients and healthy control by quick CSF methods, and the pterygium group would achieve the pterygium surgery by the same surgeon (Jin Yuan) and then be performed the contrast sensitivity test on the 1st, 3rd and 6th month postoperatively.

Procedure: Pterygium surgery

Interventions

The patients were anesthetized with subconjunctival injection.Symblepharon was released and fibrotic tissue was extensively dissected to expose the sclera and corneal stroma. The subconjunctival fibrovascular tissue, including Tenon's capsule, were thoroughly removed using scissors from the sclera and medial rectus muscle at the area of the superior and inferior fornices and the nasal caruncle. A cryopreserved human amniotic membrane (Zhongshan Ophthalmic Center, China) was then placed on the entire exposed bare sclera with the epithelial side facing upward, and secured with 10-0 nylon sutures.

primary pterygium

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

There would have two groups included in our study, which are 40 patients of primary pterygium group and 20 healthy volunteers.

You may qualify if:

  • Clinical diagnosis of the primary pterygium;
  • More than 18 and less than 60 years old;
  • or better logMAR BCVA;
  • The absence of other ocular disorders and no history of eye surgery and other systemic diseases.

You may not qualify if:

  • Clinical diagnosis of recurrent pterygium or accompanied with other ocular diseases;
  • less than 18 or more than 60 years old;
  • The logMAR BCVA is less than 0.0;
  • With the history of eye surgery and other systemic diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Opthalmic Center

Guangzhou, Guangdong, 510000, China

RECRUITING

MeSH Terms

Conditions

Pterygium

Condition Hierarchy (Ancestors)

Conjunctival DiseasesEye Diseases

Study Officials

  • Jin Yuan, Professor

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    STUDY DIRECTOR

Central Study Contacts

Jing Zhong, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 3, 2017

First Posted

January 23, 2018

Study Start

November 1, 2017

Primary Completion

November 1, 2018

Study Completion

December 31, 2018

Last Updated

January 23, 2018

Record last verified: 2018-01

Locations